ArticleJournal of medical entomology2026
Laboratory culture of Triatoma sanguisuga (Hemiptera: Reduviidae) by supplementation with Drosophila artificial hemolymph media.
Article in Journal of medical entomology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Triatoma sanguisuga (LeConte, 1855), the eastern bloodsucking conenose, is an epidemiologically significant triatomine vector in the United States in that it is implicated in documented autochthonous human Chagas disease cases in the United States and can be found across a large geographic area. Despite decades of research interest, this species has proven remarkably challenging to maintain in laboratory culture, with consistent developmental arrest occurring prior to the fifth nymphal instar stage when maintained on standard blood-only feeding protocols. Here, we report a successful protocol for maintaining T. sanguisuga through complete development in laboratory culture. Adult specimens were collected from Des Allemands, Louisiana, and maintained under standard laboratory conditions with blood feeding supplemented by Drosophila artificial hemolymph media (AHL). Early nymphal development proceeded through the third instar on blood meals alone, but development consistently stalled at the fourth instar. Following initiation of AHL supplementation, the first successful fourth-to-fifth instar molt was observed approximately 3 wk later, with subsequent emergence of adult insects occurring within 17 wk. The AHL supplement was readily consumed by nymphs when offered ad libitum at room temperature. This development overcomes a significant barrier to T. sanguisuga laboratory culture and provides compelling evidence for complex nutritional requirements in triatomines beyond those met by vertebrate blood alone. Laboratory-reared T. sanguisuga cultures will enable critical research on vector competence, feeding behavior, reproductive biology, and control measures essential for understanding and managing Chagas disease transmission in North America.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.